Remove Ethics Remove Government Remove Safety Remove Training
article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance. Training and education.

article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

Its three separate Rules (Security, Privacy, and Breach) impose a variety of security controls, documentation, governance, and notice requirements on custodians of protected health information (PHI). The HTI-1 Final Rule is an AI disclosure and governance rule published by the US Department of Health and Human Services (HHS).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Research integrity: five tips for authors, editors and reviewers

Clarivate

If the research is used to inform policy decisions around, food safety and public health, for example, then misleading and false research can risk people’s lives. Ethical publishing: an introductory course. Share your knowledge around research ethics with your peers, for example by presenting a seminar at your institution.

Ethics 106
article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

As new healthcare challenges arise and the pharmaceutical landscape evolves, the FDA may be allocating its resources to focus on other pressing issues, such as drug approvals, monitoring emerging health threats, and enhancing drug safety. The post Why Is FDA Issuing Fewer Marketing Violation Letters?

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

More convenience and safety? Hiring, training, and managing sales representatives were never cheap. Outside of the internal pressure from the pharmaceutical industry, governments around the world have also begun to crack down on pharma sales/marketing practices long considered commonplace (and highly profitable).

Pharma 52
article thumbnail

How to Work with Patient Advocates, Influencers, and Ambassadors

PM360

When asked how pharma companies could earn more trust from patients, lower drug prices and other financially supported access to treatment ranked as the top things patients would want to see along with more educational resources and support of government policies to protect patients’ rights.

article thumbnail

ESG considerations in Europe and Asia: social inclusion – the new diversity frontier in life sciences

European Pharmaceutical Review

This evolving focus is clearly visible in the growing emphasis now placed by many global businesses on environmental, social and governance (ESG) issues – and especially the ‘social’ element. ESG is an umbrella term for the tools used to measure the sustainability and ethical impact of a business. The broad landscape.